Streetbeat News

Stock Prices

HPE

Wells Fargo analyst Aaron Rakers downgraded Hewlett Packard (HPE) from Overweight to Equal-Weight and reduced the price target from $21 to $17.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 12:05 pm

TUSK

Mammoth Energy Services (NASDAQ:TUSK) reported Q4 losses of $(0.12) per share, missing the $(0.09) estimate by 33.33%, and a 220% decrease from last year's earnings. Sales were $52.78M, missing the $64.45M estimate by 18.10%, and a 48.71% decrease from last year.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 12:04 pm

LI

Li Auto Inc. (NASDAQ:LI) reported a 21.8% year-over-year increase in vehicle deliveries for February 2024, reaching 20,251 vehicles. Cumulative deliveries hit 684,780. The company announced the upcoming launch of new models, aiming for a monthly delivery target of 50,000 vehicles in March. Q4 results showed a 136.4% revenue increase to $5.88 billion with 131,805 vehicles delivered, surpassing estimates. Li Auto forecasts Q1 vehicle deliveries between 100,000 and 103,000, a 90.2% to 95.9% increase year-over-year. The company has expanded its retail and service network. Despite positive performance, LI shares dropped 2.55% to $44.71 in premarket trading.

Portfolio Pulse from Nabaparna Bhattacharya

March 01, 2024 | 12:04 pm

BBY

Recent analyst ratings for Best Buy Co (NYSE:BBY) show a mix of opinions, with 5 analysts offering views ranging from bullish to indifferent. Over the last three months, there's been a shift towards more indifferent ratings. Analysts have updated their 12-month price targets, raising the average to $82.4, indicating a 16.47% increase from the previous target. Best Buy's financial health is highlighted by its market dominance, with a notable market share in the U.S. consumer electronics sector. Despite a -7.85% decline in revenue growth over the past 3 months, the company maintains strong profitability metrics, including a net margin of 2.7% and an ROE of 9.31%.

Portfolio Pulse from Benzinga Insights

March 01, 2024 | 12:01 pm

AMRX

Amneal Pharmaceuticals' shares rose following mixed Q4 earnings report and the issuance of 2024 guidance.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 11:58 am

EMMA

ETST

GEG

Great Elm Group, Earth Science Tech, and Emmaus Life Sciences are under $2 stocks with recent insider buying activity. Great Elm Group saw a purchase by Imperial Capital Group Holdings II, LLC, while Earth Science Tech's CEO and Emmaus Life Sciences' Co-President and COO also made significant purchases. These transactions indicate insider confidence in these companies' prospects despite recent challenges such as losses and the announcement of a stock repurchase program.

Portfolio Pulse from Avi Kapoor

March 01, 2024 | 11:56 am

GDRX

JP Morgan analyst Lisa Gill upgrades GoodRx Holdings (NASDAQ:GDRX) from Neutral to Overweight and raises the price target from $7 to $10.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 11:55 am

NIO

NIO Inc. (NYSE:NIO) shares are up in premarket trading after reporting February vehicle deliveries and entering a technology license agreement with CYVN Holdings' subsidiary Forseven Limited. Despite a 33.1% year-over-year slump in February deliveries, cumulative deliveries reached 467,781. NIO is expected to report a Q4 loss of 51 cents per share on March 5, following a mixed performance in the previous quarter. NIO shares rose 1.57% to $5.84 in premarket trading.

Portfolio Pulse from Nabaparna Bhattacharya

March 01, 2024 | 11:41 am

RPID

Rapid Micro Biosystems (NASDAQ:RPID) reported Q4 earnings with an EPS of $-0.26, beating estimates by 13.0% and showing a revenue increase of $1.96 million from the previous year. Despite missing EPS estimates last quarter, the share price increased by 7% the following day. The company has shown consistent improvement in both EPS and revenue over the past four quarters.

Portfolio Pulse from Benzinga Insights

March 01, 2024 | 11:40 am

AMRX

Amneal Pharmaceuticals (NASDAQ:AMRX) reported Q4 earnings, beating estimates with an EPS of $0.14 against the expected $0.09, and revenue up $7.22 million YOY. Despite past performance showing a drop in share price following earnings beats, the company provided a positive FY 2024 earnings guidance of $0.53 to $0.63 per share.

Portfolio Pulse from Benzinga Insights

March 01, 2024 | 11:40 am